{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:55:04Z","timestamp":1791006904166,"version":"4.1.0"},"reference-count":114,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2026,8,31]]},"DOI":"10.5582\/irdr.2026.01037","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:11:28Z","timestamp":1786399888000},"page":"232-246","source":"Crossref","is-referenced-by-count":0,"title":["Phenotypic variability of Fragile-X syndrome in Asian population: A systematic review"],"prefix":"10.5582","volume":"15","author":[{"given":"Christina L Minar","family":"Napitupulu","sequence":"first","affiliation":[{"name":"Master of Biomedical Sciences majoring in Genetic Counselling, Faculty of Medicine, Universitas Diponegoro, Semarang, Central Java, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeslyn","family":"Tengkawan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Universitas Diponegoro, Semarang, Central Java, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustini","family":"Utari","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Universitas Diponegoro, Semarang, Central Java, Indonesia."},{"name":"Community Genetic Research Center (ComGenRC), Faculty of Medicine, Universitas Diponegoro, Semarang, Central Java, Indonesia."},{"name":"Center for Biomedical Research (CEBIOR), Faculty of Medicine, Universitas Diponegoro, Semarang, Central Java, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tri Indah","family":"Winarni","sequence":"additional","affiliation":[{"name":"Community Genetic Research Center (ComGenRC), Faculty of Medicine, Universitas Diponegoro, Semarang, Central Java, Indonesia."},{"name":"Center for Biomedical Research (CEBIOR), Faculty of Medicine, Universitas Diponegoro, Semarang, Central Java, Indonesia."},{"name":"Department of Anatomy, Faculty of Medicine, Universitas Diponegoro, Semarang, Central Java, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nydia Rena Benita","family":"Sihombing","sequence":"additional","affiliation":[{"name":"Community Genetic Research Center (ComGenRC), Faculty of Medicine, Universitas Diponegoro, Semarang, Central Java, Indonesia."},{"name":"Center for Biomedical Research (CEBIOR), Faculty of Medicine, Universitas Diponegoro, Semarang, Central Java, Indonesia."},{"name":"Department of Anatomy, Faculty of Medicine, Universitas Diponegoro, Semarang, Central Java, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Raspa M, Wheeler AC, Riley C. Public health literature review of fragile X syndrome. Pediatrics. 2017; 139:S153-S171.","DOI":"10.1542\/peds.2016-1159C"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Elhawary NA, AlJahdali IA, Abumansour IS, Azher ZA, Falemban AH, Madani WM, Alosaimi W, Alghamdi G, Sindi IA. Phenotypic variability to medication management: An update on fragile X syndrome. Hum Genomics. 2023; 17:60.","DOI":"10.1186\/s40246-023-00507-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Spector E, Behlmann A, Kronquist K, Rose NC, Lyon E, Reddi HV, ACMG Laboratory Quality Assurance Committee. Laboratory testing for fragile X, 2021 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021; 23:799-812.","DOI":"10.1038\/s41436-021-01115-y"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lozano R, Azarang A, Wilaisakditipakorn T, Hagerman RJ. Fragile X syndrome: A review of clinical management. Intractable Rare Dis Res. 2016; 5:145-157.","DOI":"10.5582\/irdr.2016.01048"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. G\u00f3mez-Rodr\u00edguez MJ, Morales-Conejo M, Arteche-L\u00f3pez A, S\u00e1nchez-Calv\u00edn MT, Quesada-Espinosa JF, G\u00f3mez-Manj\u00f3n I, Palma-Milla C, Lezana-Rosales JM, P\u00e9rez de la Fuente R, Martin-Ramos ML, Fern\u00e1ndez-Guijarro M, Moreno-Garc\u00eda M, Alvarez-Mora MI. Fragile X syndrome caused by maternal somatic mosaicism of FMR1 gene: Case report and literature review. Genes (Basel). 2022; 13:1609.","DOI":"10.3390\/genes13091609"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Salcedo-Arellano MJ, Hagerman RJ, Mart\u00ednez-Cerde\u00f1o V. Fragile X syndrome: Clinical presentation, pathology and treatment. Gac Med Mex. 2020; 156:60-66.","DOI":"10.24875\/GMM.M19000322"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Charalsawadi C, Wirojanan J, Jaruratanasirikul S, Ruangdaraganon N, Geater A, Limprasert P. Common clinical characteristics and rare medical problems of fragile X syndrome in Thai patients and review of the literature. Int J Pediatr. 2017; 2017:9318346.","DOI":"10.1155\/2017\/9318346"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Davidson M, Sebastian SA, Benitez Y, Desai S, Quinonez J, Ruxmohan S, Stein JD, Cueva W. Behavioral problems in fragile X syndrome: A review of clinical management. Cureus. 2022; 14:e21840.","DOI":"10.7759\/cureus.21840"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Oakes A, Thurman AJ, McDuffie A, Bullard LM, Hagerman RJ, Abbeduto L. Characterising repetitive behaviours in young boys with fragile X syndrome. J Intellect Disabil Res. 2016; 60:54-67.","DOI":"10.1111\/jir.12234"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. McCary LM, Roberts JE. Early identification of autism in fragile X syndrome: A review. J Intellect Disabil Res. 2013; 57:803-814.","DOI":"10.1111\/j.1365-2788.2012.01609.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gallagher A, Hallahan B. Fragile X-associated disorders: A clinical overview. J Neurol. 2012; 259:401-413.","DOI":"10.1007\/s00415-011-6161-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hunter J, Rivero-Arias O, Angelov A, Kim E, Fotheringham I, Leal J. Epidemiology of fragile X syndrome: A systematic review and meta-analysis. Am J Med Genet A. 2014; 164A:1648-1658.","DOI":"10.1002\/ajmg.a.36511"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Essop FB, Krause A. Diagnostic, carrier and prenatal genetic testing for fragile X syndrome and other FMR1-related disorders in Johannesburg, South Africa: A 20-year review. S Afr Med J. 2013; 103(12 Suppl 1):994-998.","DOI":"10.7196\/SAMJ.7144"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Niu M, Han Y, Dy ABC, Du J, Jin H, Qin J, Zhang J, Li Q, Hagerman RJ. Fragile X syndrome: prevalence, treatment, and prevention in China. Front Neurol. 2017; 8:254.","DOI":"10.3389\/fneur.2017.00254"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sihombing NRB, Winarni TI, Utari A, van Bokhoven H, Hagerman RJ, Faradz SMH. Surveillance and prevalence of fragile X syndrome in Indonesia. Intractable Rare Dis Res. 2021; 10:11-16.","DOI":"10.5582\/irdr.2020.03101"},{"key":"16","unstructured":"16. Limprasert P, Ruangdaraganon N, Sura T, Vasiknanonte P, Jinorose U. Molecular screening for fragile X syndrome in Thailand. Southeast Asian J Trop Med Public Health. 1999; 30 Suppl 2:114-118."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Otsuka S, Sakamoto Y, Siomi H, Itakura M, Yamamoto K, Matumoto H, Sasaki T, Kato N, Nanba E. Fragile X carrier screening and FMR1 allele distribution in the Japanese population. Brain Dev. 2010; 32:110-114.","DOI":"10.1016\/j.braindev.2008.12.015"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Movaghar A, Page D, Brilliant M, Mailick M. Prevalence of underdiagnosed fragile X syndrome in 2 health systems. JAMA Netw Open. 2021; 4:e2141516.","DOI":"10.1001\/jamanetworkopen.2021.41516"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Fazna A, Hagerman RJ. Prevalence of fragile X syndrome in South Asia, and importance of diagnosis. Med Rev (2021). 2025; 5:164-173.","DOI":"10.1515\/mr-2024-0060"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Bailey DB, Skinner D, Hatton D, Roberts J. Family experiences and factors associated with the diagnosis of fragile X syndrome. J Dev Behav Pediatr. 2000; 21:315-321.","DOI":"10.1097\/00004703-200010000-00001"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Carmichael B, Pembrey M, Turner G, Barnicoat A. Diagnosis of fragile-X syndrome: The experiences of parents. J Intellect Disabil Res. 1999; 43(Pt 1):47-53.","DOI":"10.1046\/j.1365-2788.1999.43120157.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Page MJ, McKenzie JE, Bossuyt PM, <i>et al.<\/i> The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71.","DOI":"10.1136\/bmj.n71"},{"key":"23","unstructured":"23. Kmet LM, Lee RC, Cook LS. Standard quality assessment criteria for evaluating primary research papers from a variety of fields. Alberta Heritage Foundation for Medical Research, Edmonton, Canada, 2004. <i>https:\/\/www.ihe.ca\/files\/standard_quality_assessment_criteria_for_evaluating_primary_research_papers_from_a_variety_of_fields.pdf<\/i> (accessed April 20, 2026)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Troughton A, Chin M, Amankwaa I. Nature as a therapeutic place and tool for enhancing service users&apos; engagement in mental health services: A comprehensive synthesis of evidence. Health Place. 2024; 89:103344.","DOI":"10.1016\/j.healthplace.2024.103344"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Lee L, Packer TL, Tang SH, Girdler S. Self-management education programs for age-related macular degeneration: A systematic review. Australas J Ageing. 2008; 27:170-176.","DOI":"10.1111\/j.1741-6612.2008.00298.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Faradz SMH, Buckley M, Tang L-P, Leigh D, Holden JJA. Molecular screening for fragile X syndrome among Indonesian children with developmental disability. Am J Med Genet. 1999; 83:350-351.","DOI":"10.1002\/(SICI)1096-8628(19990402)83:4<350::AID-AJMG26>3.0.CO;2-G"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Faradz SMH, Winarni TI. Focal areas of a high rate of fragile X in Indonesia: A long term follow up. Journal of Biomedicine and Translational Research. 2019; 5:67-68.","DOI":"10.14710\/jbtr.v5i2.6895"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Mundhofir FEP, Winarni TI, Nillesen W, van Bon BWM, Schepens M, Ruiterkamp-Versteeg M, Hamel BCJ, Yntema HG, Faradz SMH. Prevalence of fragile X syndrome in males and females in Indonesia. World J Med Genet. 2012; 2:15-22.","DOI":"10.5496\/wjmg.v2.i3.15"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Winarni TI, Utari A, Mundhofir FEP, Hagerman RJ, Faradz SMH. Fragile X syndrome: Clinical, cytogenetic and molecular screening among autism spectrum disorder children in Indonesia. Clin Genet. 2013; 84:577-580.","DOI":"10.1111\/cge.12095"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Utari A, Basuta K, Winarni TI, Lo J, Morales GM, Faradz SMH, Tassone F. Robust screening and cascade testing for fragile X expansions in a large multigenerational family identify many affected individuals: An experience in the remote area of Indonesia. Journal of Intellectual Disability - Diagnosis and Treatment. 2020; 8:9-15.","DOI":"10.6000\/2292-2598.2020.08.01.2"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Sihombing NRB, Cai S, Wong DPW, Guan M, Chong SS, Faradz SMH, Winarni TI. Repeat expansion and methylation-sensitive triplet-primed polymerase chain reaction for fragile X mental retardation 1 gene screening in institutionalised intellectually disabled individuals. Singapore Med J. 2021; 62:143-148.","DOI":"10.11622\/smedj.2020009"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Srour M, Shevell M. Genetics and the investigation of developmental delay\/intellectual disability. Arch Dis Child. 2014; 99:386-389.","DOI":"10.1136\/archdischild-2013-304063"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Aman MG. Aberrant behavior checklist: Current identity and future developments. Clin Exp Pharmacol. 2012; 2:e114.","DOI":"10.4172\/2161-1459.1000e114"},{"key":"34","unstructured":"34. Shen Y, Zhu N, Fan Y. Screening and genetic analysis of fragile X syndrome in Tongling Anhui province of China. Zhonghua Yi Xue Za Zhi. 1997; 77:260-262. (in Chinese)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Alanay Y, \u00dcnal F, Turanli G, <i>et al.<\/i> A multidisciplinary approach to the management of individuals with fragile X syndrome. J Intellect Disabil Res. 2007; 51(Pt 2):151-161.","DOI":"10.1111\/j.1365-2788.2006.00942.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Anvari MS, Vasei H, Najmabadi H, Badv RS, Golipour A, Mohammadi-Yeganeh S, Salehi S, Mohamadi M, Goodarzynejad H, Mowla SJ. Identification of microRNAs associated with human fragile X syndrome using next-generation sequencing. Sci Rep. 2022; 12:5011.","DOI":"10.1038\/s41598-022-08916-4"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Aoi T, Takashima H, Takada T, Okada T. Fragile X chromosome in institutionalized male adults with mental retardation. Keio J Med. 1989; 38:36-39.","DOI":"10.2302\/kjm.38.36"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Arinami T, Kondo I, Nakajima S. Frequency of the fragile X syndrome in Japanese mentally retarded males. Hum Genet. 1986; 73:309-312.","DOI":"10.1007\/BF00279092"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Arinami T, Kondo I, Nakajima S, Hamaguchi H. Frequency of the fragile X syndrome in institutionalized mentally retarded females in Japan. Hum Genet. 1987; 76:344-347.","DOI":"10.1007\/BF00272442"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Bastaki LA, Hegazy F, Al-Heneidi MM, Turki N, Azab AS, Naguib KK. Fragile X syndrome: A clinico-genetic study of mentally retarded patients in Kuwait. East Mediterr Health J. 2004; 10:116-124.","DOI":"10.26719\/2004.10.1-2.116"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Chandrasekara B, Wijesundera S, Chong SS, Perera HN. Prevalence of fragile X syndrome among children receiving special education and carrier states in first degree relatives. Ceylon Med J. 2017; 62:92-96.","DOI":"10.4038\/cmj.v62i2.8473"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Chaudhary AG, Hussein IR, Abuzenadah A, Gari M, Bassiouni R, Sogaty S, Lary S, Al-Quaiti M, Al Balwi M, Al Qahtani M. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability. Pediatr Neurol. 2014; 50:368-376.","DOI":"10.1016\/j.pediatrneurol.2013.11.020"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Chen X, Wang J, Xie H, <i>et al.<\/i> Fragile X syndrome screening in Chinese children with unknown intellectual developmental disorder. BMC Pediatr. 2015; 15:77.","DOI":"10.1186\/s12887-015-0394-8"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Dean DD, Agarwal S, Muthuswamy S. Fragile X molecular investigation and genetic counseling of intellectual disability\/developmental delay patients in an Indian scenario. Expert Rev Mol Diagn. 2019; 19:641- 649.","DOI":"10.1080\/14737159.2019.1622416"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Demirhan O, Ta\u015ftemir D, Diler RS, Firat S, Avci A. A cytogenetic study in 120 Turkish children with intellectual disability and characteristics of fragile X syndrome. Yonsei Med J. 2003; 44:583-592.","DOI":"10.3349\/ymj.2003.44.4.583"},{"key":"46","unstructured":"46. Fazeli Z, Ghaderian SMH, Najmabadi H, Omrani MD. Understanding the molecular basis of fragile X syndrome using differentiated mesenchymal stem cells. Iran J Child Neurol. 2022; 16:85-95."},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Gabis LV, Baruch YK, Jokel A, Raz R. Psychiatric and autistic comorbidity in fragile X syndrome across ages. J Child Neurol. 2011; 26:940-948.","DOI":"10.1177\/0883073810395937"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Gabis LV, Hochberg O, Leon Attia O, Banet-Levi Y, Topf D, Shefer S. Prolonged time lag to final diagnosis of fragile X syndrome. J Pediatr. 2018; 193:217-221.e1.","DOI":"10.1016\/j.jpeds.2017.10.008"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Gu F, Zhang HY, Hu SY, Huang SZ, Ma X, Zhang YQ. Erectile dysfunction in fragile X patients. Asian J Androl. 2006; 8:483-487.","DOI":"10.1111\/j.1745-7262.2006.00156.x"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Guruju MR, Lavanya K, Thelma BK, Sujatha M, OmSai VR, Nagarathna V, Amarjyothi P, Jyothi A, Anandaraj MPJS. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India. J Clin Neurosci. 2009; 16:1305-1310.","DOI":"10.1016\/j.jocn.2008.12.018"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Hong KEM, Kim JH, Moon SY, Oh SK. Chromosomal abnormalities in child psychiatric patients. J Korean Med Sci. 1999; 14:377-385.","DOI":"10.3346\/jkms.1999.14.4.377"},{"key":"52","unstructured":"52. Horiguchi T, Kaga M, Inagaki M. Assessment of chromosome and gene analysis for the diagnosis of the fragile X syndrome in Japan\u2014estimated prevalence rate in various facilities. No To Hattatsu. 2003; 35:297-303. (in Japanese)."},{"key":"53","unstructured":"53. Horiguchi T, Kaga M, Inagaki M. Assessment of chromosome and gene analysis for the diagnosis of the fragile X syndrome in Japan: annual incidence. No To Hattatsu. 2005; 37:301-306. (in Japanese)."},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Hou JW, Wang TR, Chuang SM. An epidemiological and aetiological study of children with intellectual disability in Taiwan. J Intellect Disabil Res. 1998; 42(Pt 2):137-143.","DOI":"10.1046\/j.1365-2788.1998.00104.x"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Hou F, Mao A, Shan S, Li Y, Meng W, Zhan J, Nie W, Jin H. Evaluating the clinical utility of a long-read sequencing-based approach in genetic testing of fragile-X syndrome. Clin Chim Acta. 2023; 551:117614.","DOI":"10.1016\/j.cca.2023.117614"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Iqbal MA, Sakati N, Nester M, Ozand P. Cytogenetic diagnosis of fragile X syndrome: Study of 305 suspected cases in Saudi Arabia. Ann Saudi Med. 2000; 20:214-217.","DOI":"10.5144\/0256-4947.2000.214"},{"key":"57","unstructured":"57. Jain U, Verma IC, Kapoor AK. Prevalence of fragile X(A) syndrome in mentally retarded children at a genetics referral centre in Delhi, India. Indian J Med Res. 1998; 108:12-16."},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Kabakus N, Aydin M, Akin H, Balci TA, Kurt A, Kekilli E. Fragile X syndrome and cerebral perfusion abnormalities: Single-photon emission computed tomographic study. J Child Neurol. 2006; 21:1040-1046.","DOI":"10.1177\/7010.2006.00230"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Kanwal M, Alyas S, Afzal M, Mansoor A, Abbasi R, Tassone F, Malik S, Mazhar K. Molecular diagnosis of fragile X syndrome in subjects with intellectual disability of unknown origin: Implications of its prevalence in regional Pakistan. PLoS One. 2015; 10:e0122213.","DOI":"10.1371\/journal.pone.0122213"},{"key":"60","unstructured":"60. Ke JY, Chen CL, Chen YJ, Chen CH, Lee LF, Chiang TM. Features of developmental functions and autistic profiles in children with fragile X syndrome. Chang Gung Med J. 2005; 28:551-558."},{"key":"61","unstructured":"61. Limprasert P, Ruangdaraganon N, Vasiknanonte P, Sura T, Jaruratanasirikul S, Sriwongpanich N, Sriplung H. A clinical checklist for fragile X syndrome: Screening of Thai boys with developmental delay of unknown cause. J Med Assoc Thai. 2000; 83:1260-1266."},{"key":"62","unstructured":"62. Luo XF, Zhong JM, Zhang XZ, Zou Y, Chen Y, Wu HP, Yu XY. Hair root fragile X mental retardation protein assay for the diagnosis of fragile X syndrome. Zhongguo Dang Dai Er Ke Za Zhi. 2009; 11:817-820. (in Chinese)."},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Madokoro H, Ohdo S, Sonoda T, Ohba K, Tanaka H, Hayakawa K. Infantile autism and the fragile X syndrome in Japanese children. Acta Paediatr Jpn. 1989; 31:163-165.","DOI":"10.1111\/j.1442-200X.1989.tb01283.x"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Matsuishi T, Shiotsuki Y, Niikawa N, Katafuchi Y, Otaki E, Ando H, Yamashita Y, Horikawa M, Urabe F, Kuriya N, Yamashita F. Fragile X syndrome in Japanese patients with infantile autism. Pediatr Neurol. 1987; 3:284-287.","DOI":"10.1016\/0887-8994(87)90069-5"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Mei L, Hu C, Li D, Wang Y, Li H, Zhang K, Zhou B, Zhu R, Hagerman RJ, Xu X, Xu Q. The incidence and clinical characteristics of fragile X syndrome in China. Front Pediatr. 2023; 11:1064104.","DOI":"10.3389\/fped.2023.1064104"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Moon HR, Moon SY. Fragile site X chromosomes in mentally retarded boys. J Korean Med Sci. 1993; 8:192-196.","DOI":"10.3346\/jkms.1993.8.3.192"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Nagarathinam I, Chong SS, Thelma BK, Justin Margret J, Venkataraman V, Natarajan Padmavathy K, Srisailapathy CRS. FMR1 gene CGG repeat distribution among the three individual cohorts with intellectual disability, autism, and primary ovarian insufficiency from Tamil Nadu, Southern India. Adv Genet (Hoboken). 2021; 2:e10048.","DOI":"10.1002\/ggn2.10048"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Nanba E, Kohno Y, Matsuda A, Yano M, Sato C, Hashimoto K, Koeda T, Yoshino K, Kimura M, Maeoka Y, Yamamoto T, Maegaki Y, Eda I, Takeshita K. Non-radioactive DNA diagnosis for the fragile X syndrome in mentally retarded Japanese males. Brain Dev. 1995; 17:317-321; discussion 323-324.","DOI":"10.1016\/0387-7604(95)00031-6"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Okazaki T, Adachi K, Matsuura K, Oyama Y, Nose M, Shirahata E, Abe T, Hasegawa T, Maihara T, Maegaki Y, Nanba E. Clinical characteristics of fragile X syndrome patients in Japan. Yonago Acta Med. 2021; 64:30-33.","DOI":"10.33160\/yam.2021.02.005"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Pandey UB, Phadke S, Mittal B. Molecular screening of FRAXA and FRAXE in Indian patients with unexplained mental retardation. Genet Test. 2002; 6:335-339.","DOI":"10.1089\/10906570260471903"},{"key":"71","unstructured":"71. Ruangdaraganon N, Limprasert P, Sura T, Sombuntham T, Sriwongpanich N, Kotchabhakdi N. Prevalence and clinical characteristics of fragile X syndrome at child development clinic, Ramathibodi Hospital. J Med Assoc Thai. 2000; 83:69-76."},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Saha S, Karmakar P, Chatterjee C, Banerjee D, Das S, Dasgupta UB. Fragile X syndrome in Calcutta, India. Ann Clin Biochem. 2001; 38(Pt 3):264-271.","DOI":"10.1258\/0004563011900498"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Seki N, Ishikiriyama S, Yamauchi M, Hori T. Cytogenetic and molecular analysis of dynamic mutation associated with fragile X syndrome. Jpn J Genet. 1994; 69:259-267.","DOI":"10.1266\/ggs.69.259"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Sharma D, Gupta M, Thelma BK. FMR1 haplotype analyses among Indians: A weak founder effect and other findings. Hum Genet. 2003; 112:262-271.","DOI":"10.1007\/s00439-002-0872-6"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Tan BS, Law HY, Zhao Y, Yoon CS, Ng IS. DNA testing for fragile X syndrome in 255 males from special schools in Singapore. Ann Acad Med Singap. 2000; 29:207-212.","DOI":"10.47102\/annals-acadmedsg.V29N2p207"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Tirosh E, Borochowitz Z. Sleep apnea in fragile X syndrome. Am J Med Genet. 1992; 43:124-127.","DOI":"10.1002\/ajmg.1320430119"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Tun\u00e7bilek E, Alikasifo\u011flu M, Boduro\u011flu K, Aktas D, Anar B. Frequency of fragile X syndrome among Turkish patients with mental retardation of unknown etiology. Am J Med Genet. 1999; 84:202-203.","DOI":"10.1002\/(SICI)1096-8628(19990528)84:3<202::AID-AJMG6>3.0.CO;2-O"},{"key":"78","unstructured":"78. Verma IC, Elango R. Variable expression of clinical features of Martin Bell syndrome in younger patients. Indian Pediatr. 1994; 31:433-438."},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Winarni TI, Sumekar TA, Sarjana W, Hardian H, Hagerman RJ, Faradz SMH. The aberrant behavior profile in Indonesian individuals with fragile X syndrome with limited genetic services. Intractable Rare Dis Res. 2022; 11:215-218.","DOI":"10.5582\/irdr.2022.01075"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Wong VC, Lam ST. Fragile X positivity in Chinese children with autistic spectrum disorder. Pediatr Neurol. 1992; 8:272-274.","DOI":"10.1016\/0887-8994(92)90364-5"},{"key":"81","unstructured":"81. Xu BZ, Sha R, Xiao GF, Zhou XT. A fragile X syndrome family. Chin Med J (Engl). 1984; 97:861-864."},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Zhang W, Li D, Pang N, Jiang L, Li B, Ye F, He F, Chen S, Liu F, Peng J, Yin J, Yin F. The second-tier status of fragile X syndrome testing for unexplained intellectual disability\/global developmental delay in the era of next-generation sequencing. Front Pediatr. 2022; 10:911805.","DOI":"10.3389\/fped.2022.911805"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Lachiewicz AM, Dawson DV, Spiridigliozzi GA. Physical characteristics of young boys with fragile X syndrome: Reasons for difficulties in making a diagnosis in young males. Am J Med Genet. 2000; 92:229-236.","DOI":"10.1002\/(SICI)1096-8628(20000605)92:4<229::AID-AJMG1>3.0.CO;2-K"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Romero LM, Santos GCC, Schubert V, Scalabrin EE, Herai RH. Fragile X syndrome in Brazil: Development and validation of a clinical checklist for population screening. medRxiv [Preprint]. 2025:2025.10.21.25338500.","DOI":"10.1101\/2025.10.21.25338500"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Acero-Garc\u00e9s DO, Saldarriaga W, Cabal-Herrera AM, Rojas CA, Hagerman RJ. Fragile X syndrome in children. Colomb Med (Cali). 2023; 54:e4005089.","DOI":"10.25100\/cm.v54i2.5089"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Heulens I, Suttie M, Postnov A, De Clerck N, Perrotta CS, Mattina T, Faravelli F, Forzano F, Frank Kooy R, Hammond P. Craniofacial characteristics of fragile X syndrome in mouse and man. Eur J Hum Genet. 2013; 21:816-823.","DOI":"10.1038\/ejhg.2012.265"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Lubala TK, Lumaka A, Kanteng G, Mutesa L, Mukuku O, Wembonyama S, Hagerman R, Luboya ON, Lukusa Tshilobo P. Fragile X checklists: A meta-analysis and development of a simplified universal clinical checklist. Mol Genet Genomic Med. 2018; 6:526-532.","DOI":"10.1002\/mgg3.398"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Merenstein SA, Sobesky WE, Taylor AK, Riddle JE, Tran HX, Hagerman RJ. Molecular-clinical correlations in males with an expanded FMR1 mutation. Am J Med Genet. 1996; 64:388-394.","DOI":"10.1002\/(SICI)1096-8628(19960809)64:2<388::AID-AJMG31>3.0.CO;2-9"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB, Moine H, Kooy RF, Tassone F, Gantois I, Sonenberg N, Mandel JL, Hagerman PJ. Fragile X syndrome. Nat Rev Dis Primers. 2017; 3:17065.","DOI":"10.1038\/nrdp.2017.65"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Tranfaglia MR. The psychiatric presentation of fragile X: Evolution of the diagnosis and treatment of the psychiatric comorbidities of fragile X syndrome. Dev Neurosci. 2011; 33:337-348.","DOI":"10.1159\/000329421"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Kaufmann WE, Kidd SA, Andrews HF, Budimirovic DB, Esler A, Haas-Givler B, Stackhouse T, Riley C, Peacock G, Sherman SL, Brown WT, Berry-Kravis E. Autism spectrum disorder in fragile X syndrome: Cooccurring conditions and current treatment. Pediatrics. 2017; 139(Suppl 3):S194-S206.","DOI":"10.1542\/peds.2016-1159F"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I, Tassone F, Hagerman PJ, Herman K, Hagerman RJ. Autism profiles of males with fragile X syndrome. Am J Ment Retard. 2008; 113:427-438.","DOI":"10.1352\/2008.113:427-438"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Hatton DD, Sideris J, Skinner M, Mankowski J, Bailey DB, Roberts J, Mirrett P. Autistic behavior in children with fragile X syndrome: Prevalence, stability, and the impact of FMRP. Am J Med Genet A. 2006; 140A:1804-1813.","DOI":"10.1002\/ajmg.a.31286"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Hernandez RN, Feinberg RL, Vaurio R, Passanante NM, Thompson RE, Kaufmann WE. Autism spectrum disorder in fragile X syndrome: A longitudinal evaluation. Am J Med Genet A. 2009; 149A:1125-1137.","DOI":"10.1002\/ajmg.a.32848"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95. Pay\u00e1n-G\u00f3mez C, Ramirez-Cheyne J, Saldarriaga W. Variable expressivity in fragile X syndrome: Towards the identification of molecular characteristics that modify the phenotype. Appl Clin Genet. 2021; 14:305-312.","DOI":"10.2147\/TACG.S265835"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96. Nolin SL, Glicksman A, Houck GE, Brown WT, Dobkin CS. Mosaicism in fragile X affected males. Am J Med Genet. 1994; 51:509-512.","DOI":"10.1002\/ajmg.1320510444"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97. Jiraanont P, Kumar M, Tang HT, Espinal G, Hagerman PJ, Hagerman RJ, Chutabhakdikul N, Tassone F. Size and methylation mosaicism in males with fragile X syndrome. Expert Rev Mol Diagn. 2017; 17:1023-1032.","DOI":"10.1080\/14737159.2017.1377612"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98. Ciobanu CG, Nuc\u0103 I, Popescu R, Antoci LM, Caba L, Ivanov AV, Cojocaru KA, Rusu C, Mihai CT, P\u00e2nzaru MC. Narrative review: Update on the molecular diagnosis of fragile X syndrome. Int J Mol Sci. 2023; 24:9206.","DOI":"10.3390\/ijms24119206"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99. Brand BA, Blesson AE, Smith-Hicks CL. The impact of X-chromosome inactivation on phenotypic expression of X-linked neurodevelopmental disorders. Brain Sci. 2021; 11:904.","DOI":"10.3390\/brainsci11070904"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100. Bartholomay KL, Lee CH, Bruno JL, Lightbody AA, Reiss AL. Closing the gender gap in fragile X syndrome: Review on females with FXS and preliminary research findings. Brain Sci. 2019; 9:11.","DOI":"10.3390\/brainsci9010011"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101. Bailey DB Jr, Raspa M, Bishop E, Holiday D. No change in the age of diagnosis for fragile X syndrome: Findings from a national parent survey. Pediatrics. 2009; 124:527-533.","DOI":"10.1542\/peds.2008-2992"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102. Cotter M, Archibald AD, McClaren BJ, Burgess T, Francis D, Hills L, Martyn M, Oertel R, Slater H, Cohen J, Metcalfe SA. Clinical audit of genetic testing and referral patterns for fragile X and associated conditions. Am J Med Genet A. 2016; 170:1439-1449.","DOI":"10.1002\/ajmg.a.37603"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103. Dyer-Friedman J, Glaser B, Hessl D, Johnston C, Huffman LC, Taylor A, Wisbeck J, Reiss AL. Genetic and environmental influences on the cognitive outcomes of children with fragile X syndrome. J Am Acad Child Adolesc Psychiatry. 2002; 41:237-244.","DOI":"10.1097\/00004583-200203000-00002"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104. Hessl D, Dyer-Friedman J, Glaser B, Wisbeck J, Barajas RG, Taylor A, Reiss AL. The influence of environmental and genetic factors on behavior problems and autistic symptoms in boys and girls with fragile X syndrome. Pediatrics. 2001; 108:e88.","DOI":"10.1542\/peds.108.5.e88"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105. Greenberg J, Seltzer M, Baker J, Smith L, Warren SF, Brady N, Hong J. Family environment and behavior problems in children, adolescents, and adults with fragile X syndrome. Am J Intellect Dev Disabil. 2012; 117:331-346.","DOI":"10.1352\/1944-7558-117.4.331"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106. Glaser B, Hessl D, Dyer-Friedman J, Johnston C, Wisbeck J, Taylor A, Reiss AL. Biological and environmental contributions to adaptive behavior in fragile X syndrome. Am J Med Genet A. 2003; 117A:21-29.","DOI":"10.1002\/ajmg.a.10549"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107. Winarni TI, Schneider A, Borodyanskara M, Hagerman RJ. Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile X syndrome. Case Rep Genet. 2012; 2012:280813.","DOI":"10.1155\/2012\/280813"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108. Cole JJ, Killian E, Sellitto AD, Ramsey A, Balls-Berry JE, Gurnett C. Social determinants of health, the diagnostic odyssey, and genetic testing for global developmental delay\/intellectual disability: A qualitative study. Res Sq [Preprint]. 2026 Jan 28:rs.3.rs-8378360.","DOI":"10.21203\/rs.3.rs-8378360\/v1"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109. Faugno E, Galbraith AA, Walsh K, Maglione PJ, Farmer JR, Ong MS. Experiences with diagnostic delay among underserved racial and ethnic patients: A systematic review of the qualitative literature. BMJ Qual Saf. 2025; 34:190-200.","DOI":"10.1136\/bmjqs-2024-017506"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110. Sherman S, Pletcher BA, Driscoll DA. Fragile X syndrome: Diagnostic and carrier testing. Genet Med. 2005; 7:584-587.","DOI":"10.1097\/01.GIM.0000182468.22666.dd"},{"key":"111","doi-asserted-by":"crossref","unstructured":"111. Lyon E, Laver T, Yu P, Jama M, Young K, Zoccoli M, Marlowe N. A simple, high-throughput assay for fragile X expanded alleles using triple repeat primed PCR and capillary electrophoresis. J Mol Diagn. 2010; 12:505-511.","DOI":"10.2353\/jmoldx.2010.090229"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112. Sihombing NRB, Winarni TI, de Leeuw N, van Bon B, van Bokhoven H, Faradz SMH. Genetic diagnostic approach to intellectual disability and multiple congenital anomalies in Indonesia. Intractable Rare Dis Res. 2023; 12:104-113.","DOI":"10.5582\/irdr.2023.01001"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113. Vasudevan P, Suri M. A clinical approach to developmental delay and intellectual disability. Clin Med (Lond). 2017; 17:558-561.","DOI":"10.7861\/clinmedicine.17-6-558"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114. Rodan LH, Stoler J, Chen E, Geleske T; Council on Genetics. Genetic evaluation of the child with intellectual disability or global developmental delay: Clinical report. Pediatrics. 2025; 156:e2025072219.","DOI":"10.1542\/peds.2025-072219"}],"container-title":["Intractable &amp; Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/15\/3\/15_2026.01037\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:35:42Z","timestamp":1791005742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/15\/3\/15_2026.01037\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":114,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2026.01037","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"article-number":"2026.01037"}}